A Tough Nut to Crack: The Complexities of Allergy - European Medical Journal

A Tough Nut to Crack: The Complexities of Allergy

Allergy & Immunology

The EMJ Podcast | Episode 161

This week, Jonathan is joined by Drew Bird, Director of the Food Allergy Center at Children’s Health, Dallas, Texas, USA, to dive into environmental factors that have led to the increase in allergies, including peanut allergy, and oral immunotherapy as a treatment for allergies. The pair further discuss misconceptions and misinformation around allergies, and which allergies need more attention.

Spotify | Apple | Amazon MusicDownload MP3 (35:56 mins)


Speaker bio:

Drew Bird received his medical degree from the University of Texas Medical School in San Antonio, USA, before completing a Paediatrics residency and a fellowship in Allergy and Immunology at Baylor College of Medicine in Houston, Texas, USA. He is a Professor of Pediatrics and Internal Medicine within the Division of Allergy and Immunology at the University of Texas Southwestern Medical Center in Dallas, and Director of the Food Allergy Center at Children’s Health, also in Dallas. Bird was the inaugural recipient of the American Academy of Allergy, Asthma and Immunology/Food Allergy Initiative Howard Gittis Memorial Award, which led to a clinical research fellowship in food allergy at Duke University in Durham, North Carolina, USA. He is a frequent recipient of ‘best doctor’ awards.

In his spare time, Drew enjoys spending time with his wife and three young children, as well as gardening, travelling, watching college football, and birdwatching.


Prof Bird has the following disclosures: Consultant for AllerGenis, Allergy Therapeutics, Ltd, Before Brands, DBV Technologies, FARE, Genentech, HAL Allergy, Novartis, and Nutricia; and has received grant funding (institution) from Aimmune, Astellas, DBV Technologies, FARE, Genentech, NIH NIAID, Novartis, Regeneron and Siolta.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?